From BioPolicyWiki
Revision as of 16:45, 1 May 2009 by Jreynolds (Talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Region Asia
Population 1,132,446,000
GDP (millions USD) 1,098,945
National Policies
Eggs for assisted reproduction no policy
Eggs for research no policy
Inheritable genetic modification PROHIBITED
Preimplantation genetic diagnosis social uses prohibited
Reproductive cloning PROHIBITED
Research cloning regulated
Sex selection "social uses prohibited" is not in the list of possible values (?, PROHIBITED, regulated, Social uses prohibited, no policy) for this property.
Surrogacy commercial allowed
International Agreements
2005 UN Cloning Vote no
2005 UNESCO Sports Doping Convention RATIFIED


Key laws and policies

Prohibited practices

Sex selection by any means is prohibited in the Pre-Natal Diagnostic Techniques Amendment Act, which was subsequently amended to reflect technological developments. The Indian Council of Medical Research’s National Guidelines for Accreditation, Supervision and Regulation of ART Clinics permits an exception for sex selection by PGD "to avoid the risk of transmission of a genetic abnormality assessed through PGD."

Reproductive cloning and inheritable genetic modification are prohibited by the Department of Biotechnology's Ethical Policies on the Human Genome, Genetic Research and Services, the Indian Council of Medical Research's Ethical Guidelines for Biomedical Research on Human Participants, and the Council's Guidelines for Stem Cell Research and Therapy.

Permitted and regulated practices

Preimplantation genetic diagnosis is allowed in case of suspected medical conditions based on parental history, including both genetic conditions and the age of the mother.

Commercial surrogacy was legalized in 2002, and loosely regulated under 2005 guidelines from the Indian Council of Medical Research.[1] In February 2008, the Ministry of Women and Child Development considered new legislation.[2]

Providing eggs for assisted reproduction is permitted under guidelines, which do allow payments.[3] For research, however, only the reimbursement of expenses is allowed.[4]


  1. Mahendra Kumar Singh, "New laws to rein in 'womb business'," Times of India (October 31, 2007)
  2. Amelia Gentleman, "India Nurtures Business of Surrogate Motherhood," New York Times (March 10, 2008)
  3. American Society for Reproductive Medicine, "IFFS Surveillance 07," Fertility and Sterility (Vol. 87. No. 4, Suppl. 1, April 2007)
  4. Singapore Bioethics Advisory Committee, Donation Of Human Eggs For Research: A Consultation Paper (November 7, 2007)